Effect of interferon-beta1b on magnetic resonance imaging outcomes in secondary progressive multiple sclerosis: results of a European multicenter, randomized, double-blind, placebo-controlled trial. European Study Group on Interferon-beta1b in secondary progressive multiple sclerosis.
Miller, D H
Effect of interferon-beta1b on magnetic resonance imaging outcomes in secondary progressive multiple sclerosis: results of a European multicenter, randomized, double-blind, placebo-controlled trial. European Study Group on Interferon-beta1b in secondary progressive multiple sclerosis. [electronic resource] - Annals of neurology Dec 1999 - 850-9 p. digital
Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
0364-5134
10.1002/1531-8249(199912)46:6<850::aid-ana7>3.0.co;2-q doi
Brain--pathology
Disease Progression
Double-Blind Method
Europe
Follow-Up Studies
Humans
Interferon beta-1a
Interferon beta-1b
Interferon-beta--therapeutic use
Magnetic Resonance Imaging
Multiple Sclerosis--drug therapy
Placebos
Recombinant Proteins--therapeutic use
Time Factors
Effect of interferon-beta1b on magnetic resonance imaging outcomes in secondary progressive multiple sclerosis: results of a European multicenter, randomized, double-blind, placebo-controlled trial. European Study Group on Interferon-beta1b in secondary progressive multiple sclerosis. [electronic resource] - Annals of neurology Dec 1999 - 850-9 p. digital
Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
0364-5134
10.1002/1531-8249(199912)46:6<850::aid-ana7>3.0.co;2-q doi
Brain--pathology
Disease Progression
Double-Blind Method
Europe
Follow-Up Studies
Humans
Interferon beta-1a
Interferon beta-1b
Interferon-beta--therapeutic use
Magnetic Resonance Imaging
Multiple Sclerosis--drug therapy
Placebos
Recombinant Proteins--therapeutic use
Time Factors